コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 es of deep brain stimulation (DBS; essential tremor).
2 modality that can be used to treat essential tremor.
3 thin the tremor physiologic range may worsen tremor.
4 that relate to clinical features of dystonic tremor.
5 thy invariably associated with a distinctive tremor.
6 patients with dystonic tremor and essential tremor.
7 neurosurgery for treatment of drug-resistant tremor.
8 r and the majority had additional upper-limb tremor.
9 t unerupted, teeth; and cerebellar intention tremor.
10 roving severe, refractory multiple sclerosis tremor.
11 the lithium group tended to experience more tremor.
12 is anterior muscle and the onset of hindlimb tremor.
13 ad]) for the treatment of multiple sclerosis tremor.
14 surgery has been applied in the treatment of tremor.
15 the treatment of patients with pathological tremor.
16 osis of well-known causes, such as essential tremor.
17 copies of the LINGO1 gene also present with tremor.
18 stic biomarkers for functional myoclonus and tremor.
19 nuclei was sufficient to generate an action tremor.
20 around 10 Hz, thereby reducing physiological tremor.
21 ent problems such as rigidity, slowness, and tremor.
22 radykinesia (slowed movement), rigidity, and tremors.
23 s were encephalopathy (57%), headache (42%), tremor (38%), aphasia (35%) and focal weakness (11%).
24 arkinson disease) = 303; n(dystonia) = 64; n(tremor) = 39; n(treatment-resistant depression/anorexia
25 athisia, the most common adverse events were tremor (42 [79%] patients in the quetiapine-ER group vs
27 neuromuscular reflex-related phenotype (e.g. tremors accompanied by clonus) of Amish nemaline myopath
29 p brain stimulation to a particular phase of tremor afforded clinically significant tremor relief (up
34 cell connectivity as a neural substrate for tremor and a gateway for signals that mediate the diseas
35 Moreover, severe motor impairment, resting tremor and abnormal gait and posture, phenotypes reminis
36 ant clinical presentation, e.g. paralysis or tremor and additional symptomatology such as cognitive s
37 patients produced exacerbation of grip-force tremor and associated changes in functional activation.
38 the effect of visual feedback on grip-force tremor and associated functional network-level activatio
41 ntial (VsEP) responses to jerk stimuli, head tremor and deficits in balance beam tests that are consi
42 dard of care in Parkinson disease, essential tremor and dystonia, and is also under active investigat
43 tosomal dominant familial cortical myoclonic tremor and epilepsy (FCMTE), a syndrome not yet official
44 that differs substantially between dystonic tremor and essential tremor and should be further explor
46 functional connectivity networks in dystonic tremor and essential tremor groups relative to controls.
47 activation and connectivity between dystonic tremor and essential tremor patient cohorts to better un
49 vity z-scores were able to classify dystonic tremor and essential tremor with 89% area under the curv
50 , which can discriminate Parkinson's disease tremor and essential tremor with high diagnostic accurac
51 fication performance for Parkinson's disease tremor and essential tremor, in both test and validation
53 y body disease; resting tremor, pill-rolling tremor and hallucinations were more frequent in Lewy bod
54 s show abnormal gait and locomotor activity, tremor and memory deficits, but human disorders related
56 and crying, jerky myoclonic postural/action tremor and polyminimyoclonus) and seven disability miles
57 examine the association between genotype and tremor and postural instability and gait difficulty (PIG
58 stonic tremor can resemble that of essential tremor and present a diagnostic confound for clinicians.
59 parkinsonian syndromes (PS), from essential tremor and probable dementia with Lewy bodies (DLB) from
60 ts in WT alphaS mice and the PD-like resting tremor and progressive motor decline of 3K alphaS mice.
62 r, peripheral trauma-induced tremor, tardive tremor and rabbit syndrome, paroxysmal tremors (heredita
63 tially between dystonic tremor and essential tremor and should be further explored in implementing ap
64 cluding seizures, encephalopathy, myoclonus, tremor and spasticity, with immunotherapy responsiveness
67 ervical dystonia patients with dystonic head tremor and the majority had additional upper-limb tremor
69 Parkinson's disease, essential and dystonic tremor and tremor related to multiple sclerosis (MS) and
70 le and female subjects affected by essential tremor and undergoing deep brain stimulation surgery, ve
72 ased on limb-specific paresis and paralysis, tremors and seizures, and other clinical signs, along wi
74 rs off ("off periods"), medication-resistant tremor, and dyskinesias, benefit from advanced treatment
75 ement disorders such as Parkinson's disease, tremor, and dystonia involves the placement of focal les
77 tion effectiveness in reducing bradykinesia, tremor, and rigidity was evaluated for each electrode co
79 d 20 postural tremor recordings in essential tremor, and validated on a second, independent cohort co
81 hysiological (as distinct from pathological) tremor are an unavoidable component of human motor contr
84 side effect rate of lesional treatments for tremor are presented separately alongside this article.
85 t expert consensus labelled the incidence of tremor as a core feature of dystonia that can affect bod
89 ive diseases, including fragile X-associated tremor ataxia syndrome (FXTAS), ALS, and frontotemporal
97 common in patients with fragile X-associated tremor/ataxia syndrome (FXTAS), with no targeted treatme
98 expanded CGG repeats in fragile X-associated tremor/ataxia syndrome is initiated at an upstream ACG n
102 been hypothesized as the prime generator of tremor because of the pacemaker properties of ION neuron
104 yndrome, paroxysmal tremors (hereditary chin tremor, bilateral high-frequency synchronous discharges,
105 ed ultrasound (FUS) thalamotomy in essential tremor, but its effectiveness and safety for managing tr
106 cleus neurons, which might produce an action tremor by causing signal oscillations during movement.
107 trated improvements in medication-refractory tremor by CRST assessments, even in the setting of a pla
112 the same time, clinical features of dystonic tremor can resemble that of essential tremor and present
114 ia syndrome, spinocerebellar ataxia type 12, tremors caused by autosomal recessive cerebellar ataxias
116 movement disorders (parkinsonism, dystonia, tremor, chorea, and restless legs syndrome) were include
118 subthalamic nucleus fell outside our Holmes tremor circuit, whereas the globus pallidus target was c
119 inical features included progressive ataxia, tremor, cognitive decline, dysphagia, optic atrophy, dys
121 tatement of the Movement Disorder Society on tremor coined a new term: essential tremor-plus (ET-plus
122 ly anterolaterally, to fibers beneficial for tremor control as published by Al-Fatly et al in 2019.
123 ve programming strategies to achieve optimal tremor control without speech impairment in essential tr
125 ression) in selected patients with essential tremor despite delivering less than half the energy of c
126 ale fault marked by clusters of non-volcanic tremors directly beneath the southern Central Range.
127 Essential tremor (ET) is the most common tremor disorder globally and is characterized by kinetic
132 ced differences in neural activation between tremor dominant (TD) and postural instability/gait diffi
134 tudinally, EDS in PD was associated with non-tremor dominant phenotype, autonomic dysfunction, depres
135 ut its effectiveness and safety for managing tremor-dominant Parkinson disease (TDPD) is unknown.
136 ication design on two independent cohorts of tremor-dominant Parkinson patients sampled brain activit
137 hort comprising 16 rest tremor recordings in tremor-dominant Parkinson's disease and 20 postural trem
138 ventional and incisionless interventions for tremor due to Parkinson's disease, essential and dystoni
140 visual feedback similarly exacerbated force tremor during the grip-force task in dystonic tremor and
143 inetic movement disorders, namely, essential tremor, dystonia, Huntington disease and other chorea sy
144 tions such as Parkinson's disease, essential tremor, dystonia, obsessive-compulsive disorder, and epi
145 Pathologies such as Parkinson's disease and tremor emerge when brain regions controlling movement ca
149 ials and Methods Participants with essential tremor (ET) or Parkinson disease (PD) undergoing thalamo
150 reened 662 subjects comprising 462 essential tremor (ET) subjects (285 sporadic, 125 with family hist
163 f the ET network support oscillations at the tremor frequency and the application of a DBS-like input
165 k exhibited oscillatory behaviour within the tremor frequency range, as did our electrophysiological
166 facilitate sustained oscillatory activity at tremor frequency throughout the network as well as a rob
169 cts were far more widespread in the dystonic tremor group as changes in functional connectivity were
172 s, such as Parkinson's disease and essential tremor, has encouraged its application to a wide range o
173 rdive tremor and rabbit syndrome, paroxysmal tremors (hereditary chin tremor, bilateral high-frequenc
175 n motor thalamus FA 1 day after ablation and tremor improvement (ET: R = -0.52 [P = .03]; PD: R = -0.
179 cing cerebellar Purkinje cell output blocked tremor in mice that were given the tremorgenic drug harm
186 , plantarflexion contractions, physiological tremor increases as the ankle joint becomes plantarflexe
187 e spastic ataxia with frequent occurrence of tremor, involvement of the central sensory tracts and de
192 how in awake behaving mice that the onset of tremor is coincident with rhythmic Purkinje cell firing,
198 high-frequency synchronous discharges, head tremor, limb-shaking transient ischaemic attack), bobble
201 t whether lesion locations that cause Holmes tremor map to a connected brain circuit and whether this
204 nson's disease, but also occurs in essential tremor, most prominently for the coupling of alpha to ga
207 der globally and is characterized by kinetic tremor of the upper limbs, although other clinical featu
214 Using a promising animal model for action tremor, our results thus characterized a synaptic circui
216 tivity between dystonic tremor and essential tremor patient cohorts to better understand disease-spec
217 his study demonstrates that SID in essential tremor patients is associated with both motor cortex and
218 Prior work using this paradigm in essential tremor patients produced exacerbation of grip-force trem
219 ed worsening of intelligibility in essential tremor patients with bilateral thalamic deep brain stimu
224 e tremor, Wilson's disease, slow orthostatic tremor, peripheral trauma-induced tremor, tardive tremor
227 n cerebellar nuclei, which also reversed the tremor phenotype in the traditional harmaline-induced es
228 J-background, Lyst-mutant mice exhibit overt tremor phenotypes associated with loss of cerebellar Pur
231 in all mutation carriers, together with the tremor physiology studies performed in family 2, suggest
232 han patients with Lewy body disease; resting tremor, pill-rolling tremor and hallucinations were more
234 al diagnosis of PS, non-PS (mainly essential tremor), probable DLB, and non-DLB (mainly Alzheimer dis
236 t of their tremor with the Tolosa-Fahn-Marin Tremor Rating Scale (TRS) during optimised VIM or VO lea
238 dominant Parkinson's disease and 20 postural tremor recordings in essential tremor, and validated on
239 assessed in a test cohort comprising 16 rest tremor recordings in tremor-dominant Parkinson's disease
240 rt, cheap, widely available and non-invasive tremor recordings, and is independent of operator or pos
243 s disease, essential and dystonic tremor and tremor related to multiple sclerosis (MS) and midbrain l
244 alamic high-frequency stimulation suppressed tremor-related activity in thalamus but increased the os
246 se of tremor afforded clinically significant tremor relief (up to 87% tremor suppression) in selected
248 ability-gait impairment and with predominant tremor revealed asymmetries for step length in both coho
250 omatic, focused on improvement in motor (eg, tremor, rigidity, bradykinesia) and nonmotor (eg, consti
252 prediagnostic motor (hypo- and bradykinesia, tremor, rigidity, postural imbalance, postural abnormali
253 nce problems (RR, 8.9; 95% CI, 2.3 to 34.8); tremors (RR, 7.5; 95% CI, 1.9 to 29.9); weakness in legs
255 mf11, which causes reduced body size, evoked tremor, seizures, muscle stiffness, and morbidity by pos
256 recurrent inhibition may function to reduce tremor.SIGNIFICANCE STATEMENT We present the first direc
257 ore motor features of the disease, including tremor, slowing of movement (bradykinesia), and rigidity
263 a robust new neurophysiological measure, the tremor stability index, which can discriminate Parkinson
264 on), characteristic movement difficulty (eg, tremor, stiffness, slowness), and psychological or cogni
265 t 3 months in the on-medication treated hand tremor subscore from the Clinical Rating Scale for Tremo
266 rage research into the creation of essential tremor subsets that are defined with respect to differen
267 nically significant tremor relief (up to 87% tremor suppression) in selected patients with essential
268 parvalbumin neurons in mice caused an action tremor syndrome resembling the core symptom of essential
269 recognition and treatment of various unusual tremor syndromes in the adult and paediatric populations
270 ommentary on this article.Misdiagnosis among tremor syndromes is common, and can impact on both clini
271 rthostatic tremor, peripheral trauma-induced tremor, tardive tremor and rabbit syndrome, paroxysmal t
272 ed the early-onset twisting, stiff limbs and tremor that is observed in dystonia, a debilitating move
276 dysmetria can be quantified independently of tremor using fast, reverse-at-target goal-directed movem
277 treatments of refractory multiple sclerosis tremor using lesioning or deep brain stimulation (DBS) h
278 FAME) is characterised by cortical myoclonic tremor usually from the second decade of life and overt
281 ure that endpoint accuracy was unaffected by tremor, we quantified dysmetria in selected trials manif
282 data acquired during treatments of essential tremor, we verified that our simulation framework can be
283 Patients with dystonic tremor and essential tremor were characterized by distinct functional activat
284 yrexia, nasopharyngitis, sleep disorder, and tremor were the most frequent adverse events in patients
286 stent with a unique sarcomeric origin of the tremor, which we classify as "myogenic tremor." ANN NEUR
287 We identified 36 lesions causing Holmes tremor, which were scattered across multiple different b
288 bellar ataxias, myorhythmia, isolated tongue tremor, Wilson's disease, slow orthostatic tremor, perip
289 le to classify dystonic tremor and essential tremor with 89% area under the curve, whereas combining
292 drive to produce increases in physiological tremor with muscle shortening - while successfully repli
294 llowed by blinded safety assessment of their tremor with the Tolosa-Fahn-Marin Tremor Rating Scale (T
295 unctional connectivity compared to essential tremor within higher-level cortical, basal ganglia, and
297 commonly used for parkinsonism and essential tremor, worsened incoordination, and frequencies within
298 n help individuals with medication-resistant tremor, worsening symptoms when the medication wears off